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The Thy-1 differentiation alloantigen is expressed as one of two allelic forms, 
Thy-l.1 (formerly theta-AKR) or Thy-l.2 (formerly theta-C3H) encoded for by 
Thy-1  a or Thy-1  b, respectively, in the various strains of mice (1-5).  Only the 
analogue of the Thy-1  a allele has been found in rats (6-9). Thy-1 is expressed in 
large quantities by cells in the brain and thymus of both species (1-3,  6-9). 
Smaller amounts are found on peripheral thymus-derived (T) lymphocytes and 
epidermal cells from the  mouse (1,  10-12).  Although most rat  peripheral  T 
lymphocytes do not express Thy-1, approximately 30-40% of bone marrow cells 
express the molecule (8, 9, 13). Thy-1 has also been found on fibroblast-derived 
cell lines from mice and rats (14). The rat analogue of Thy-1.1 has been purified 
and shown to be a glycoprotein with a mol wt of 24,000 daltons for brain Thy-1 
(15) and two forms of 25,000 and 27,000 daltons for thymocyte Thy-1 (16). The 
molecular nature of the murine Thy-1 molecule is still a matter of controversy. 
Murine Thy-1 has been reported by various investigators as glycolipid (17), 
ganglioside (18), protein (19-21),  or a glycoprotein (22, 23). 
Our approach to resolving this matter was to isolate sufficient quantities of 
Thy-1.1 and Thy-l.2 for a detailed structural and functional analysis. Mouse and 
rat thymocytes bind more than 500,000 molecules of Thy-1 antibody per cell in 
direct-binding assays (8, 24). We have taken advantage of the fact that many 
murine lymphocytic leukemic cell lines express Thy-1 in amounts equal to or 
greater than that found on normal thymocytes (25-27).  In addition these cells 
can be adapted to grow in suspension culture (28). By using large-scale mamma- 
lian cell culture we can now produce a  kilogram or more of cells per week. 
Procedures have been effected for isolating large quantities of membrane from 
these  cells  for  study  (29,  30). In  this  report  the  isolation  and  preliminary 
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characterization of the Thy-l.1 molecule from an AKR-derived T-lymphoblas- 
toid cell line BW5147 will be described. 
Materials and Methods 
Cell  Culture.  BW5147  cell line was obtained from the Cell Distribution  Center of the Salk 
Institute for Biological Studies,  San Diego, Calif. This spontaneously  derived AKR T-lympho- 
blastoid cell line which expresses large amounts of the Thy-1.1 alloantigen and lesser amounts of 
H-2K  k (30), was adapted to large-scale suspension culture at the Cell Culture Center of the Uni- 
versity of Alabama in Birmingham,  and grown as previously described (27,  30) using 2% horse 
or fetal calf serum.  2  x  1011 cells or more were collected and processed to the membrane stage 
daily. 
Antisera.  Congenic anti-Thy-l.1 and anti-Thy-l.2 sera were prepared using AKR/Cum (Cum- 
berland Farms, Clinton, Tenn.) and AKR/Jax (The Jackson Laboratory, Bar Harbor, Maine) mice 
as previously described (27, 28). Anti-Thy-l.1 was used at an initial dilution of 1:125 for AKR/Jax 
thymocytes and 1:75 for rat thymocytes. Anti-Thy-l.2 was used at 1:8. Rabbit anti-mouse brain 
serum was produced according to the method described by Golub (31),  and has been shown to be 
specific for Thy-1 when assayed on rat or mouse thymocytes (32-36). 
An  antiserum  was  raised  in  rabbits  against  purified  Thy-1  preparations  from  an  AcA-34 
column. The first two injections administered 10 days apart consisted of 50 ~g intravenously (i.v.) 
and 50 t~g subcutaneously in complete Freund's adjuvant. After six weekly bleedings beginning 10 
days after the second injection, the titer decreased.  The rabbits were then boosted with 50  ~tg 
purified Thy-1 i.v. and bled weekly for four additional weeks. All antisera was heat inactivated at 
56°C for 30 rain and stored at -20°C before use. 
Quantitation of Thy-1.  Cytotoxicity assay procedures were a  modification of the s~Cr-release 
assay (37) described by Williams et al. (38). 50 ~1 each of the absorbed antiserum, a 1 x  107 cell/ml 
suspension of 51Cr-labeled thymocytes and a  1:8 dilution of guinea pig serum (Texas Biological 
Labs., Inc., Fort Worth, Texas) as a source of complement were added to each well of a microtiter 
plate. Ai~r incubation at 37°C for 45 min the plates were centrifuged at 1,500g for 10 min and 100 
~1 of the supernate was counted in a Beckman Bio-Gamma II gamma counter (Beckman Instru- 
ments, Inc., Fullerton, Calif.). 
The amount of Thy-1 in a  given sample was measured by quantitative absorption of cytotoxic 
antiserum (27, 28, 39). 50 pl of antiserum at the appropriate dilution was added to an equal volume 
of serial dilutions of the sample, mixed, and incubated at 4°C for 2 h. All dilutions were carried 
out in buffer containing 15% bovine serum albumin (BSA)  ~  to counteract the effect ofdeoxycholate 
(DOC)  in the samples.  After centrifugation  for  10 min at  1,500 g,  50  /~l of the supernate  was 
removed and  monitored for residual  cytotoxic activity.  The  residual  activity in  the  absorbed 
antiserum was expressed as: 
counts released by absorbed antiserum  - 
I  counts released in complement control  ] 
% absorption =  100 ........  x  100. 
[ counts released by unabsorbed  antiserum  - 
counts released in complement control 
The percent absorption was plotted vs. the amount of protein used for absorption. The amount of 
protein in micrograms required to reduce a microliter of antiserum to the 50% absorption level is 
defined as one unit of activity. Data are expressed in units of activity per milligram of protein. 
Protein concentration was determined according to the method of Lowry et al. (40) using BSA as a 
standard. 
Membrane Isolation.  Cells were collected from suspension culture by continuous flow centrifu- 
gation using a  Sharpies T-1P Super Centrifuge equipped with a no. 1-H standard  clarifier rotor 
(Sharpies-Stokes  Div., Pennwalt  Corp.,  Warminster,  Pa.)  at a  flow rate  of approximately  100 
liters/h (41). The cells were resuspended to 1 ×  l0  s cells/ml in 10 mM Tris plus 0.15  M NaC1, pH 
~Abbreviations  used  in  this paper:  BSA, bovine serum  albumin;  DOC,  deoxycholate; SDS- 
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7.4, and disrupted in a Stansted model AO 612 cell disrupter (Stansted Energy Service Co., Wash- 
ington, D. C.) equipped with a model 716 disrupting valve (29). A flow rate of 2 liters/h was utilized 
with a back pressure of 300 lb/in  2 on the disrupting valve. Nuclei and cell debris were pelleted from 
the cell homogenate at 400g for 15 min. This supernate was centrifuged for 20 rain at 4,000g in a 
Beckman J-21B centrifuge using a JA-14 rotor (Beckman Instruments, Inc.). The resulting super- 
nate was centrifuged at an average of 20,000 g  for 1 h to generate a microsomal pellet. This pellet 
was resuspended in 10 mM Tris-HCl, pH 8, and stored at -70°C. No difference has been detected 
between membranes that have been frozen at this step or used directly. 
Acetone Precipi~tion.  Frozen membranes were rapidly thawed and added with mixing to ten 
volumes of -70°C acetone. The membrane-acetone mixture was mixed several times, centrifuged 
at 3,000 g  for 15 min, and the supernate discarded. 
Solubilization  of t~e Acetone  Powder.  The  acetone  pellet  was  homogenized  in  a  Dounce 
homogenizer in 2% sodium DOC  (Calbiochem, La Jolla, Calif.) in 10 mM Tris-HC1, pH 8.0,  at a 
final concentration of 5 mg protein/ml. After incubation at 4°C for 2 h with stirring, the insoluble 
material was removed by centrifugation at 100,000 g  for 1 h. 
Lectin Affinity Chromatography.  Lens culinaris lectin coupled to Sepharose 4B was prepared 
by  the  method  of Allan et  al.  (42).  Between  1  and  2  mg of lectin was  coupled/ml  of packed 
Sepharose. The column was equilibrated and run in 0.5% DOC, 10 mM Tris, pH 8,2. The 100,000g 
supernate of the DOC-solubilized acetone powder was applied to the column and after washing off 
the unbound material, the bound material was eluted with 3% alpha-methyl-D-glucoside in the 
same buffer. 
Ethanol Precipitation.  Three volumes of absolute ethanol and a few drops of saturated sodium 
acetate were added to each fraction and incubated at -20°C. The ethanol solution was frequently 
concentrated 10-fold on a  PM-10 Amicon filter (Amicon Corp.,  Lexington, Mass.) before incuba- 
tion. After 48 h, the suspension was centrifuged at 300 g for 15 min, the ethanol poured off, and the 
pellet resuspended in the appropriate buffer. 
Gel Filtration.  Gel  filtration  was  carried  out  on  a  2.5  ×  100  cm  Ultrogel  AcA-34  (LKB 
Instruments, Inc., Rockville, Md.) column in 0.5% DOC  10 mM Tris.HC1,  pH 8.2, or a  Sepharyl 
S-200 column (Pharmacia, Inc., Piscataway, N. J.). 
Polyacrylamide Gel Electrophoresis.  Sodium dodecyl sulfate-polyacrylamide gel electrophore- 
sis (SDS-PAGE) was performed according to the method used by Laemmli et al.  (43) using 10% 
acrylamide gels. The gels were stained with Coomassie Blue (44). 
Results 
Cytotoxic Assay System.  Our original assay system of congenic anti-Thy-1.1 
tested on AKR/Jax target cells gave quantitative results for intact cells and 
membranes but proved ineffective  in detecting Thy-1.1 after DOC solubilization 
of the membranes (Fig.  1 A). Even at protein concentrations in excess of i mg/ml 
the solubilized material gave less than 20% absorption. Two alternative assay 
systems were investigated to  alleviate this problem.  One system which con- 
sisted  of congenic anti-Thy-l.1 tested on  rat  thymocyte targets allowed for 
detection of Thy-l.1 after DOC solubilization but was still less effective than 
before addition of the detergent (Fig.  1 B).  Approximately 10 times as much 
solubilized material was required as intact membranes for a 50% reduction. The 
second alternative Thy-l-specific detection system evaluated was rabbit anti- 
mouse brain serum tested on rat target cells.  As illustrated in Fig.  1 C this 
system was equally effective in detecting Thy-1 before and after solubilizaton 
with detergent. For this reason, the rabbit anti-mouse brain system was used to 
monitor the Thy-1 activity during the purification procedure. 
Purification of Thy-1.  In effect the procedure was conducted in two stages: 
(a) Isolation of membranes, which were stored at -70°C and (b) solubilization 
and purification of Thy-1 from the frozen membranes. 
The purification scheme for Thy-1 from BW5147 membranes is shown in Fig. ROBERT  K.  ZWERNER,  PAUL  A.  BARSTAD,  AND  RONALD  T.  ACTON  989 
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Fro. I.  An evaluation of cytotoxic  assay systems for the detection of Thy-l. Plasma 
membranes of BW5147 cells  were prepared according to the text.  The membranes were 
solubilized  in  2% DOC and centrifuged  at  100,000  g (100  K) for  i  h. The  plasma membrane- 
and DOC-solubilized supernate were used  to absorb  congenic antiserum and tested  on (A) 
AKR/Jax (1:125  dilution)  or (B) rat (1:75  dilution)  thymocytes and (C) rabbit anti-mouse 
brain serum(l:32 dilution)  tested  on rat  thymocytes. 
2. A representative total yield and purification for each step is indicated in Table 
I. A crude membrane preparation was generated by use of differential centrifu- 
gation procedures described by Allan and Crumpton (45). The 20,000 g  (micro- 
somal) pellet contained 6% of the disrupted cell protein and 27% of the Thy-1 990  PURIFICATION  OF  MILLIGRAM  QUANTITIES  OF  Thy-l.1 
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FIG.  2.  Purification scheme for Thy-l.1. Crude membranes were isolated by differential 
centrifugation. P indicates pellet fractions and S indicates supernates. All operations were 
performed at 4°C. 
activity of the cells. Although the pellets were washed after the 400g and 4,000g 
centrifugation steps,  P1  and P2  still  retained some residual specific  Thy-l.1 
activity as  these were negative when tested with  anti-Thy-l.2 serum as  a 
control.  Only  a  small  amount of Thy-1  activity remaining in  the  20,000 g 
supernate could be pelleted by centrifugation at 100,000 g for 1 h. Routinely 25- 
50% of Thy-1 activity was recovered in the microsomal pellet which contained 
5-7% of the protein of the disrupted cells. The yield of H-2K  k paralleled Thy-1 at 
all steps indicating that the loss of activity was indeed due to total membrane 
loss (P. A. Barstad, unpublished observations). 
Frozen membranes were rapidly thawed and added to  -70°C acetone. This 
step  reduced the  amount of lipid  and lipoprotein present in  the membrane 
preparation resulting in better solubilization with DOC and more efficient flow 
through the Lens  culinaris  column. Approximately 33%  of the protein was ROBERT  K.  ZWERNER,  PAUL  A.  BARSTAD,  AND  RONALD  T.  ACTON 
TABLE  ] 
Purification of Thy-1.1 from BW5147 Lymphoblastoid Cells 
991 
Fraction  Total pro-  Total ac-  Protein  Purifica-  Yield 
tein  tivity  tion 
mg  units/  %  % 
fraction 
Cells  20,160  471.2  100  1  100 
400 g  supernate  11,495  351.6  57.0  1.3  74.6 
400 g  pellet  4,960  141.0  24.6  1.2  30.0 
4,000 g  supernate  7,550  364.2  37.4  2.1  77.3 
4,000 g  pellet  768  75.0  3.8  4.2  15.9 
20,000 g  supernate  8,250  152.6  40.9  0.8  32.4 
20,000 g  pellet  1,150  125.1  5.7  4.7  26.8 
Acetone pellet in DOC  758  170.1  3.8  9.6  36.1 
100,000 g  supernate  289  150.0  1.4  22.2  31.8 
100,000 g  pellet  437  3.6  2.2  0.4  0.8 
Lectin column concentrate  11  94.3  0.06  356.5  20.0 
AcA-34 column concentrate  1  50.0  0.005  2,139.0  10.6 
removed at this step with no loss of Thy-1 activity. The apparent increase in 
Thy-1 activity was thought to be due to difficulty in obtaining a homogeneous 
suspension for absorption assays. The acetone pellet was solubilized in 2% DOC 
at a protein concentration of 5 mg/ml and centrifuged at 100,000 g  for 1 h. The 
Thy-1 activity remained in the supernate which contained approximately 40% of 
the protein. 
The  100,000 g  supernate  was passed  over a  Lens culinaris  lectin affinity 
column and the bound material eluted with alpha-methyl-v-glucoside (Fig. 3). 
The fractions were assayed for Thy-1 activity and the active fractions concen- 
trated by ethanol precipitation. Under nonsaturating conditions, all detectable 
Thy-1 activity bound to the lectin column. Approximately 4-5% of the protein 
applied to the column was eluted with alpha-methyl-v-glucoside and contained 
63% of the Thy-1 activity applied, resulting in a 16-fold purification at this step. 
After ethanol precipitation, the alpha-methyl-D-glucoside eluted fraction was 
chromatographed on an AcA-34 column (Fig. 4). The fractions containing Thy-1 
activity eluted after an ovalbumin standard and followed fractions active for H- 
2K  k. After concentration by ethanol precipitation, 1% of the protein applied to 
the column and 50% of the Thy-1 activity was recovered in these fractions. This 
fraction represented greater than a 2,000-fold final purification. 
SDS-PAGE.  Before SDS-PAGE, the sample was chromatographed on a  S- 
200 column and precipitated by ethanol. The purity of the Thy-1 fraction is 
demonstrated in Fig. 5.  The mol wt using this gel system was calculated as 
approximately 25,000 daltons. 
Antiserum against Purified Thy-1.1.  Rabbit antiserum to the purified Thy- 
1.1  molecule was prepared and analyzed for activity against mouse and rat 
thymocytes. The titer utilizing a  50% cytotoxicity end point against AKR/Jax 
(Fig. 6 A) and AKR/Cum thymocytes (1:512) was essentially identical. The titer 
of this antiserum was 1:20 against rat thymocytes and 1:128 against BW5147 
cells (Fig. 6 B). 
No absorption was observed when the antiserum was incubated with AKR/ 992  PURIFICATION  OF  MILLIGRAM  QUANTITIES  OF  Thy-l.1 
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FIG.  3.  Lens culinaris  lectin affinity column. The DOC-solubilized 100,000 g supernate 
was applied to the lectin column and washed with 10 mM tris-HC1, pH 8.2, containing 0.5% 
DOC. Elution of the glycoprotein fraction was by 3% a-methyl-D-glucoside in the above 
buffer which was applied beginning at fraction 32. Thy-1 activity was assayed using rabbit 
anti-mouse brain serum  (1:32) and rat thymocytes as target cells. 
Jax liver and analyzed against mouse or rat thymocytes. However, AKR/Jax 
brain  and  thymus membranes  completely absorbed the  cytotoxic activity for 
both target cells. BW5147 cells and AKR/Jax thymocytes were equally effective 
in  removing  the  rabbit  anti-purified  Thy-l.1  activity when  tested  on  either 
AKR/Jax thymocytes (Fig. 6 A) or BW5147 cells (Fig. 6 B). 
Since heterologous antiserum was utilized to follow the activity of Thy-1 it 
was important to ascertain if the purified molecule in the absence of detergent 
would absorb the mouse congenic anti-Thy-1.1 serum. Purified Thy-1.1 was used 
to absorb mouse congenic and rabbit anti-purified Thy-1 sera. The purified Thy- 
1.1  effectively absorbed cytotoxic activity from both antisera  (Fig.  7).  These 
results  indicate  that  the  purified  component  is  Thy-l.1  and  that  these  two 
antisera  recognize  the  same  molecule.  It  is  interesting  to  note  that  a  more 
purified Thy-l.1 was required to absorb congenic antiserum when assayed on 
AKR/Jax thymocytes as opposed to rat thymocytes. Little difference was evident 
using the two target cells when purified Thy-1.1 was used to absorb rabbit anti- 
purified Thy-1.1. 
Discussion 
In our early work on the purification of Thy-1.1 using congenic antisera with 
mouse target cells, we were unable to detect Thy-1 activity after the solubiliza- 
tion of the membranes with DOC. In contrast, Letarte-Muirhead et al. (46) had 
demonstrated  that  DOC  did  not destroy  rat  Thy-1  activity.  However,  these ROBERT  K.  ZWERNER,  PAUL  A.  BARSTAD,  AND  RONALD  T.  ACTON  993 
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FIG.  4.  Fractionation on AcA-34 column. The glycoprotein fraction eluted from the affinity 
column was applied to an AcA-34 column and run in 10 mM Tris-HC1, pH 8.2, containing 
0.5% DOC.  5-ml fractions were collected and assayed for Thy-1 activity using rabbit anti- 
mouse brain serum  (1:32  dilution) on rat thymocytes.  H-2K  k activity was  assayed using 
(C3H. H-2  °  x  129)F1 anti-C3H spleen (antiserum D-3b obtained from Dr.  John Ray at the 
NIH) tested on AKR/Jax spleen target cells. 
FIG.  5.  SDS-PAGE.  Standards  (A)  consisting  of  10  /~g  each of BSA  (65,000  daltons), 
ovalbumin (OVA) (45,000 daltons), and chymotrypsinogen (CHY) (25,000 daltons). The Thy- 
1 fraction from the AcA-34 column (B) ran with the same mobility as chymotrypsinogen. 
The gels were stained with Coomassie Blue. 994  PURIFICATION  OF  MILLIGRAM  QUANTITIES  OF  Thy-l.1 
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FIG.  6.  Titration of rabbit anti-purified Thy-1 serum. Antiserum was reacted with AKR/ 
Jax thymocytes (A) or BW5147  cells (B) before and after absorption with BW5147  cells or 
AKR/Jax thymocytes. A  1:8 dilution of the antiserum was absorbed twice with an equal 
volume of packed cells for 1 h  each on ice. 
investigators were utilizing mouse anti-rat brain serum assayed on AKR mouse 
thymocytes by use of a  radioactive-binding  assay.  This suggested that  either 
mouse and rat Thy-1 differ extensively or that our assay system was unable to 
detect detergent-solubilized Thy-1.  We therefore evaluated the  ability of con- 
genic mouse antiserum as opposed to rabbit anti-mouse brain serum to recognize 
solubilized Thy-1 when mouse or rat thymocytes were utilized as target cells. As 
shown in Fig. 1, these antisera differed extensively in their abilities to detect the 
Thy-1 molecule after solubilization. Rabbit anti-mouse brain serum when tested 
on rat  thymocytes gave  the  clearest  results  and  allowed  us  to  detect Thy-1 
activity after solubilization.  Therefore,  this system was utilized to quantitate 
activity during the purification procedure. 
There  are  several  possible explanations  why these  antisera  differ in  their 
ability to detect Thy-1 after detergent solubilization.  It should be pointed out 
that  in  the  purification  scheme absorption  of cytotoxic activity was effective 
with whole cells and the various subcellular fractions. After the solubilization in 
DOC it was not possible to precipitate antigen-antibody complexes in microtiter 
plates, and the absorption procedure became in effect an inhibition assay. After I00 
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Fro.  7.  Absorption of rabbit anti-purified  Thy-1  and congenic antisera with purified ~y- 
1.  The puttied  Thy-l.1  was used to absorb rabbit anti-purified  Thy-1  tested on AKR/Jax 
(1:125 dilution) and rat (1:8 dilution) thymocytes. Congenic antiserum was used for absorp- 
tion at 1:125 dilution for AKR/Jax and 1:75 dilution for rat thymocytes. 
the absorption phase soluble antigen-antibody  complexes were transferred to 
the cytotoxic phase which could then dissociate and combine with Thyol on the 
target cells. When enough antibody had attached to the target cell, lysis would 
occur, giving the same result as if no absorption had taken place. The affinity of 
the antiserum for Thy-l.1 in the solubilized form as opposed to that for Thy-l.1 
on the cell surface determines how much of this exchange occurred and thus 
influenced the accuracy of detection. One possible explanation for the observed 
difference in results with antisera analyzed on rat and mouse target cells is that 996  PURIFICATION  OF  MILLIGRAM  QUANTITIES  OF  Thy-l.1 
congenic antiserum  has  a  lower affinity for the rat  cell  surface Thy-l.1  as 
opposed to mouse cell surface Thy-1.1 and much less antibody exchange takes 
place after transfer. Such a hypothesis also implies that the antiserum has a low 
affinity for the solubilized murine Thy-1.1. 
Williams et al. (47) and Morris et al. (35, 36) have suggested that the rat Thy-1 
molecule possesses a series of antigenic determinants which may vary in their 
stability or accessibility in detergent. Congenic antisera detect only the Thy-1.1 
or Thy-1.2 determinant. However, the rabbit anti-mouse brain serum recognizes 
little,  if any,  Thy-l.l-specific determinants  and  most  of the  antibodies  are 
directed toward the mouse-rat cross-reactive determinants on rat cells or mouse- 
rat cross-reactive in addition to mouse-specific determinants on AKR/Jax and 
AKR/Cum thymocytes. Therefore, antibodies against two determinants would 
have to be absorbed out for mouse targets and antibodies against only one deter- 
minant for rat target cells. The majority of the antibodies in rabbit anti-mouse 
brain are for the mouse-specific determinant. Each of these epitopes may differ 
in their susceptibility to denaturation by detergent depending on their location 
and whether they are carbohydrate or polypeptide in nature. A second explana- 
tion would be a  differential effect of DOC binding and structurally hindering 
these epitopes. We are presently pursuing these questions in an effort to deter- 
mine which if any of the above explanations is valid. 
Esselman and Miller (18) have demonstrated Thy-l-like activity in ganglio- 
side GM, and Grab while Arndt et al. (48) found a lipid moiety was necessary to 
retain full antigenic activity. In our studies the acetone and ethanol precipita- 
tion steps that were used during purification should have removed the majority 
if not all of the lipid but did not affect the Thy-1 activity. While not empirically 
conclusive this  would  indicate  that  Thy-1  activity resides  in  a  glycoprotein 
moiety.  While  Trowbridge  and  Hyman  (22) claim  that  Thy-1  specificity is 
related  to  the  carbohydrate moiety others  have  found loss  of activity after 
protease digestion (20,  47).  It will necessitate a  thorough study to determine 
which antigenic moieties are being recognized by the various antisera and what 
components are essential for the antigenic determinants. 
Letarte-Muirhead et al.  (16) reported the existence of at least two different 
types of Thy-1.1 molecules on rat thymocytes. These two forms differed in their 
molecular weight, carbohydrate composition, and ability to bind to lentil lectin. 
In contrast all the Thy-1 purified from BW5147  cells binds to the lentil lectin 
column and gives a single band on SDS-PAGE. This discrepancy may be due to 
our use of a relatively homogenous T-lymphoblastoid cell line. If two forms do 
exist in the mouse, however, they must be very similar antigenically as indi- 
cated with our serological studies, i.e., the Thy-l.1 purified from BW5147  cells 
can totally inhibit cytotoxic activity for rat and mouse thymocytes. 
In the mouse Thy-1 has been demonstrated on nerve endings (49) in addition 
to being expressed primarily on T cells. It has been suggested that Thy-1 and 
other "differentiation alloantigens" may play some role in cell-cell recognition 
(50).  This could be either a  general role involving some common anchor or it 
could be one of specificity, i.e., it could allow only the correct cells to interact 
resulting in proliferation of the T  cells or synaptogenesis in the brain.  One 
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of microheterogeneity between different cells. If the specificity function is true 
for Thy-1, one would expect to find microheterogeneity within the Thy-1 mole- 
cules from different populations of T  cells analogous to immunoglobulins. To 
investigate  this  possibility  rabbit  antiserum  against  purified  Thy-l.1  from 
BW5147  cells was  absorbed with BW5147  cells or AKR/Jax  thymocytes and 
assayed against either BW5147 cells or AKR/Jax thymocyte targets (Fig. 6). If 
Thy-1 were a heterogeneous collection of molecules, rabbit anti-purified Thy-1 
serum should recognize ~variable"  portions of the pelypeptide chains which 
differ from cell to cell as well as constant region determinants shared by all Thy- 
1-positive  cells.  In  such  a  case  normal  thymocytes should  not  remove the 
"variable" region antibody made against a cell line Thy-1. As shown in Fig. 6A 
Thy-l.1 from BW5147 has all the major determinants found on normal thymo- 
cytes and conversely normal thymocytes totally absorb all the activity against 
BW5147 cells (Fig. 6B). This indicates that the Thy-l.1 molecule expressed by 
BW5147  cells has  no major antigenic determinants which are  not found in 
comparable  amounts  of pooled thymus cells.  These  data  indicate  that  the 
existence of variable and constant regions in Thy-l.1 are unlikely and suggest 
that the molecule must play some less specific role, if any, in cell-cell interac- 
tion. 
As indicated in Table I, only 25% of  the Thy-1 activity of  the cells was obtained 
in the microsomal pellet. This is probably due to suboptimal cell disruption 
conditions resulting in a heterogeneous mixture of membrane fragments. As we 
gain more experience in processing large volumes of cells we anticipate increas- 
ing our membrane yield significantly. As an alternative we have tried Tween-40 
solubilization on intact cells following the procedure of Morris et al.  (36) but 
found only a slight increase in yield. Moreover the approach presented difficul- 
ties in handling large quantities of cells on a day to day basis. We are presently 
attempting to  modify our isolation and purification scheme to decrease our 
losses and to be able to purify components present in lesser quantities on cell 
membranes. 
This isolation of Thy-1 is the first report describing the purification of milli- 
gram quantities of a  lymphoblastoid cell surface component. Our approach to 
Thy-1  was  greatly  influenced by  the  desire  to  obtain  multiple cell  surface 
antigens from a single cell line, more specifically to obtain in addition to Thy- 
1.1, H-2, and gp69/71 from the BW5147 cell line. Although these molecules are 
present in much smaller amounts than Thy-1  (reference 30,  and Kim Wise, 
unpublished observations) on BW5147 cells we have adapted conditions allowing 
us to partially purify them simultaneously with Thy-1. Further purification of 
these molecules is currently underway in our laboratory. 
Summary 
The Thy-l.1 molecule was isolated from the BW5147 murine lymphoblastoid 
cell line. The initial step in purification was the preparation of a crude plasma 
membrane fraction followed by acetone precipitation. The acetone pellet was 
solubilized using deoxycholate (DOC) and Thy-1.1 was purified by use of a Lens 
culinaris  lectin  affinity  column and  an  AcA-34  gel  filtration  column.  The 
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daltons. The isolation  of  this  molecule was effected  by detecting Thy-I activity 
utilizing  rabbit anti-mouse brain serum tested on rat thymocytes. Congenic 
anti-Thy-l.1 serum was ineffective  in detecting Thy-l.1 after  DOC  solubiliza- 
tion. An antiserum prepared in rabbits to the purified  Thy-1.1 was found to be 
cytotoxic  to mouse and rat thymocytes. The cytotoxic  activity  of  this  antisera 
could be completely absorbed with AKR/Jax  brain and thymus but was not 
absorbed by liver.  In addition, AKR/Jax thymocytes totally  absorbed all cyto- 
toxic  activity  of  the rabbit anti-purified  Thy-1 serum for BW5147 cells  suggest- 
ing  that  the cell  line  shares identical  specificities  with normal thymocytes. The 
purified Thy-1.1 molecule was able to totally  absorb the cytotoxic activity  of 
mouse congenic anti-Thy-1. These studies serve as a model for the isolation  of 
other murine lymphoid cell surface components in quantities for detailed struc- 
tural and functional analysis. 
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